Nanovis is a cutting edge nano technology company exclusively focused on using nanostructured implant surfaces, biomaterials and growth factors to develop tissue regenerating implants for bone and soft tissues. Nanovis’ technology applies to metal, polymer and ceramic composite implants and offers a powerful combination of tissue integration, reduced inflammatory response and resistance to bacterial colonization.

Nanovis’ team is uniquely focused and capable with a select group of experts in implant nanotechnology, bone growth peptides, bone physiology, device and pharmaceutical development. Our team, equipped with state of the art nanotechnology development, implant prototyping and manufacturing facilities, and a broad intellectual property portfolio assembled from Purdue University, Brown University and Renssellaer Polytechnic Institute, have allowed Nanovis to quickly become a leading pioneer in using nanotechnology and synergistic peptides to develop implants and biomaterials with important clinical improvements and patent protected competitive advantages.

Nanovis values strategic relationships with industry leaders highly as a way to quickly improve clinical care for large numbers of patients. Nanovis offers deep expertise within the implant nanotechnology field to help improve or differentiate the existing products of our partners or the potential for commercialization relationships related to novel Nanovis products under development. Nanovis also brings a promising  intellectual property portfolio targeting implant nanosurfaces, composite materials, biomaterials and bone growth peptides. Nanovis  approaches each relationship in the spirit of innovation and integrity and has strategic relationships in place in the orthopedic, soft tissue repair and cardiovascular fields.

We welcome exploratory discussion with companies interested in expanding or improving their implant or biomaterial portfolio in orthopedics, soft tissue repair, wound healing, cardiovascular surgery, urogential surgery and other implant fields. We have broad array of strategic relationship ready technology for your review and invite you to contact us for a discussion about how we could address an opportunity or add value to your product line.

Nanovis’ product development programs focus nanostructured biomaterials used for bone augmentation and wound healing as well as implant nanosurfaces used for orthopedics, soft tissue implants and wound healing.